Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

NCT05478304 is registered in ClinicalTrials.gov with AtriCure, Inc. as lead sponsor.

NCT NCT05478304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05478304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
Lead sponsor
AtriCure, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 25, 2023
Completion date
April 30, 2032
Enrollment
6,573 (actual)
Sites
138

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, systemic embolism